Dr. Joseph M. Pepek, MD

Dr. Pepek practices at University Medical Center Medical Center in Plainsboro in North Brunswick, New Jersey.

Dr. Pepek's NPI, 1790755304, was assigned on January 25, 2006. Dr. Pepek graduated from Georgetown University School of Medicine in 2003. Dr. Pepek holds New Jersey license 25MA09125200.

Dr. Pepek's primary practice is University Medical Center Medical Center in Plainsboro, at 2777 Us-1, North Brunswick, NJ 08902 in Middlesex County. The practice phone is (732) 407-0401.

Dr. Pepek's primary practice is University Medical Center Medical Center in Plainsboro in North Brunswick, New Jersey. Dr. Pepek is also affiliated with Hospital of the University of Pennsylvania. The medical group on file is Regional Cancer Care Associates. Dmand AI also links Dr. Pepek to 2 more hospitals, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Pepek practices, 5 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Pepek's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dmand AI has Dr. Pepek's licenses on file in 5 states: New Jersey, California, North Carolina, Pennsylvania and Virginia.

CMS data shows 3,845 Medicare services from Dr. Pepek across 27 procedure codes in 2024, for 523 Medicare patients. Medicare paid $621,537 for them.

CMS counts 523 Medicare patients who saw Dr. Pepek in 2024. The largest group is 75 to 84, with 239 patients. 75% of them have cancer, and 75% have high blood pressure. 4% are also on Medicaid. Their average risk score is 1.63, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Pepek's median patient age at 74, with 53% women.

In 2024, Dr. Pepek wrote 123 Medicare Part D claims for 73 patients. 92% of them were for generic drugs. CMS names the drug for 15 of them, across 1 drug with 11 or more claims each, at $218 in total drug cost. In 2023, CMS named 40 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Pepek for performance year 2024, reported as part of a group. Dr. Pepek accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Pepek as offering telehealth.

Dmand AI links 8 papers to Dr. Pepek, published from 2011 to 2020. The most frequent topics are Carcinoma, Non-Small-Cell Lung, Lung Neoplasms and Positron-Emission Tomography. Dr. Pepek has published most often in Pract Radiat Oncol. Dr. Pepek's most frequent co-authors are Manisha Palta, MD, Junzo Paul Chino, MD and Thomas A. D'Amico, MD.

CMS Open Payments shows 29 general payments to Dr. Pepek from 16 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 53% of the total. Varian Medical Systems, Inc. paid the most, $1,369.

Dr. Pepek graduated from Georgetown University School of Medicine in 2003.